Fondation MSF

Name

Fondation MSF

Legal name

Médecins Sans Frontières (MSF)

Website

https://msf.fr

Company type

Private

Founded year

1971

Operating status

Operating

Headcount range

501–1,000 employees

Ownership category

akta.pro rank

Product category

Humanitarian Medical Innovation

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731), Biological Products, (No Disgnostic Substances) (2836), Services-Health Services (8000)

akta.pro primary industry

Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC)

akta.pro secondary industries

Women’s Health & Reproductive Specialty Pharmaceuticals (HLAIACAN), Funding, Reimbursement & Vaccines-for-Children (VFC)/Public Purchase Programs (HLAJAHAK)

Keywords

• Humanitarian medical innovation
• Medical research funding
• Mobile diagnostic applications
• Epidemic surveillance systems
• 3D printed medical devices

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Others, Technology or R&D, Marketing or Sales

Revenue model

1. Private donations and philanthropy: Nearly all resources (99.7%) come from private sources including individual donors, major donors, and philanthropists. MSF France received support from over 500,000 donors in France in 2024. Total resources in 2024 were €582.2M.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Fondation MSF develops and finances medical innovation projects that deliver new diagnostic, treatment, and care delivery tools for use in MSF humanitarian field programs. Its portfolio includes the Antibiogo AI-powered antibiogram app, the Alerte-Epidémies digital surveillance platform, the Programme 3D prosthetics and burn-mask initiative, the Optimilk F-60 malnutrition treatment modernization, the AI4CC cervical cancer screening project, the DKA Calculator, the DiaTROPIX rapid diagnostic test platform, and the Mini-Lab transportable bacteriology laboratory, all designed for low-resource, fragile settings.

Product overview

La Fondation MSF delivers medical innovation solutions that improve patient care in humanitarian settings. The organization operates a portfolio of distinct medical technology projects: Antibiogo (AI-powered antibiogram interpretation app), AI4CC (cervical cancer screening with AI), Programme 3D (prosthetics and compression masks via 3D printing), Optimilk F-60 (malnutrition treatment modernization), DKA Calculator (diabetic ketoacidosis management), Micropatchs (needle-free vaccination technology), TDR Rougeole et Méningite (rapid diagnostic tests via DiaTROPIX), Mini-Lab (transportable bacteriology laboratory), Alerte-Épidémies (epidemic surveillance digital platform), Étude Fièvre Jaune (fractional dose vaccine research), and rehabilitation care programs. These products range from deployed technologies to research-stage innovations, addressing diagnostic, treatment, and care delivery gaps in resource-limited humanitarian contexts.

Differentiator

Problem solved

Functional benefit

Brands

• Antibiogo: Free, open-source Android application for antibiotic resistance diagnosis, enabling non-expert laboratory technicians to measure and interpret antibiograms.
• Programme 3D
• Alerte-Épidémies
• Optimilk F-60
• AI4CC
• DKA Calculator
• Micropatchs
• diaTROPIX
• Mini-Lab
• CRASH
• SMS AFYA-YETU

Products and services

• Antibiogo A free, open-source, offline Android application that helps non-expert laboratory technicians measure and interpret antibiograms to combat antibiotic resistance, enabling appropriate antibiotic prescription in low-resource settings.
• AI4CC (Artificial Intelligence for Cervical Cancer) A clinical study in Malawi improving cervical cancer screening through the combined action of a PCR test and Artificial Intelligence, as part of MSF's program for care of women with cervical cancer.
• Programme 3D A program using 3D scanning and printing technology to design and print custom prosthetics for amputees and compression masks for facial burns patients, deployed in Jordan, Haiti, and Gaza.
• Optimilk F-60 A medical research and innovation project to modernize Ready-to-Use Therapeutic Food (RUTF) used to treat severe acute malnutrition in children worldwide.
• DKA Calculator A digital calculation tool to guide healthcare workers in managing diabetic ketoacidosis in children with type 1 diabetes, adapted for use in low-resource field conditions without specialists.
• Micropatchs A research project preparing the use of vaccine micropatches — a needle-free, painless vaccination technology with improved thermal stability for humanitarian contexts.
• TDR Rougeole et Méningite (DiaTROPIX) A non-profit platform at Institut Pasteur Dakar for the development and production of rapid diagnostic tests (RDTs) for measles and meningitis in countries with limited laboratory access.
• Mini-Lab A small-scale, autonomous, transportable clinical bacteriology laboratory designed for MSF field conditions, affordable and suited to resource-limited intervention areas.
• Alerte-Epidémies A digital platform for processing and notifying epidemic alerts to detect and respond to outbreaks of measles, meningitis, cholera, and COVID-19 in fragile settings, implemented in partnership with the Ministry of Health of Niger.
• Étude Fièvre Jaune (Yellow Fever Fractional Dose Study) A clinical trial led by Epicentre proving that a 1/5th dose of yellow fever vaccine offers equivalent protection to a full dose, with results published in The Lancet.
• Développement de l'offre de rééducation (Rehabilitation Care Program) A program implementing new rehabilitation practices in pediatrics, for burn patients, and in women's health (including pelvic floor rehabilitation) across MSF field operations.

Quantifiable outcome

• Antibiogo published in Nature Communications, 2021
• +3 more outcomes

Named customers4 records

Segments2 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature8 records

Partnerships

15 partnerships are on record, tiered core and major.

• EpicentrecoreStrategic or Co-development Partner · 1 January 2020MSF's epidemiology research center providing technical expertise for epidemic surveillance projects (Alerte-Epidémies) and clinical trials (Yellow Fever study, Antibiogo evaluation). Collaborates on study design, data analysis, and field epidemiology.
• Medic MobilecoreTechnology or Integration · 1 January 2020Technology partner developing the mobile application platform for Alerte-Epidémies. Provides software development expertise for offline-capable epidemic alert systems.
• Ministry of Health of NigercoreStrategic or Co-development PartnerGovernment health authority partnering on epidemic surveillance digitalization. Ministry was the primary beneficiary and co-designer of the Alerte-Covid19 and Alerte-Niger applications.
• Institut Pasteur DakarcoreStrategic or Co-development PartnerHosts the DiaTROPIX platform for development and production of rapid diagnostic tests for measles and meningitis. Provides manufacturing infrastructure and regulatory expertise.
• Kenya Medical Research Institute (KEMRI)coreStrategic or Co-development PartnerConducts the YEFE clinical trial for fractional yellow fever vaccination in Kenya. One of two research sites for the study (1630 participants total across Kenya and Uganda).
• University of OxfordcoreStrategic or Co-development PartnerAcademic research partner in the Yellow Fever fractional dose study (YEFE). Collaborates on study design and scientific analysis.
• Institut of Tropical Medicine AntwerpmajorStrategic or Co-development PartnerAcademic partner in Mini-Lab project contributing expertise in tropical medicine and laboratory development.
• Biologie Sans FrontièresmajorStrategic or Co-development PartnerHumanitarian laboratory organization contributing expertise to Mini-Lab design and deployment.
• WHOcoreStrategic or Co-development PartnerWorld Health Organization developed fractional dose recommendations for yellow fever vaccination in 2016. Epicentre's study was designed to generate evidence to support WHO policy change.
• Dr Dan LeachcoreStrategic or Co-development PartnerBritish pediatrician who developed the original DKA calculator tool. Partnered with Fondation MSF to adapt the tool for field use in low-resource settings.
• British Society for Paediatric Endocrinology and DiabetesmajorStrategic or Co-development PartnerProfessional medical body that has endorsed the DKA calculator tool developed by Dr Dan Leach.
• EQWAL FoundationmajorStrategic or Co-development PartnerNew partner for the 3D Program, supporting compression mask and prosthetic development for burn patients.
• MSF LogistiquecoreImplementation/ SI/ Consulting PartnerMSF's logistics subsidiary providing supply chain and equipment procurement support for Mini-Lab and other operational projects.
• Global GoodmajorTechnology or IntegrationIntellectual venture focused on technology for global health impact, supporting Mini-Lab development.
• Google.orgmajorStrategic or Co-development PartnerPresented Antibiogo at VivaTech 2022 on Google.org's stand. Supports humanitarian technology projects.

Scale indicators12 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• PATH: PATH is a global health innovation nonprofit developing and deploying health solutions (vaccines, diagnostics, devices) for low-resource settings. Comparable as a nonprofit developing medical innovations like Antibiogo, DiaTROPIX, and Mini-Lab, with similar focus on bridging market gaps for vulnerable populations.
• Partners in Health: Partners in Health provides healthcare services in resource-limited settings globally, with strong focus on accompanying national health systems. Comparable as a humanitarian health organization delivering care in similar geographies (Haiti, Rwanda, Sierra Leone, Malawi) with similar nonprofit funding model.
• Foundation for Innovative New Diagnostics (FIND): FIND is a global nonprofit focused on developing and delivering diagnostic tests for diseases of poverty. Directly comparable mission to Antibiogo, DiaTROPIX, and Mini-Lab projects, with similar focus on diagnostic innovation for resource-limited settings.
• International Rescue Committee: IRC is a major humanitarian aid organization providing health care, education, and emergency relief in crisis settings. Comparable as a Western-based nonprofit delivering health services in conflict zones with private donor funding and similar operational footprint in the geographies Fondation MSF serves.
• Médecins Sans Frontières International: MSF International is the parent movement of MSF France and Fondation MSF, coordinating 25+ national sections that deliver humanitarian medical care in conflict and crisis zones. Directly comparable mission, operational model, and funding structure (private donations), with even larger scale across the MSF movement.
• Drugs for Neglected Diseases Initiative: DNDi is a nonprofit R&D organization developing new treatments for neglected diseases affecting low-income populations. Directly comparable as a medical innovation-focused nonprofit addressing market gaps in global health, with similar partnership model (WHO, academic institutions, pharma companies).

Broad incumbents

• Gavi, the Vaccine Alliance: Gavi is a public-private partnership improving vaccine access in lower-income countries. Comparable as a major global health organization operating in the same geographies, with strong overlap on Fondation MSF's Micropatchs and yellow fever vaccine work.
• UNICEF: UNICEF is the UN agency providing humanitarian and developmental aid to children worldwide, including immunization programs and health services. Comparable as a major global health organization addressing similar population health challenges (malnutrition, vaccination, epidemic response) across overlapping geographies.
• Wellcome Trust: Wellcome Trust is a major charitable foundation funding global health research and innovation. Comparable as a major privately-funded foundation with comparable resources supporting health R&D, including diagnostics and vaccine innovation relevant to Fondation MSF's portfolio.
• International Committee of the Red Cross: The ICRC is the world's largest humanitarian organization, providing medical assistance in conflict zones alongside MSF. Directly comparable as a Nobel-recognized (multiple Nobel Peace Prizes) humanitarian medical organization with comparable funding scale and operational footprint in war zones.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/msf_france
• YouTubeyoutube.com/@msffrontlines
• Facebookfacebook.com/medecins.sans.frontieres
• LinkedInlinkedin.com/company/médecins-sans-frontières-france
• Instagraminstagram.com/msf_fr

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fondation MSF